Gyl Financial Synergies, LLC Sanofi Transaction History

Gyl Financial Synergies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$45.75 - $52.48 $5,490 - $6,297	-120 Reduced 0.84%	14,096 $685,000
Q4 2023 Feb 09, 2024	SELL	$43.13 - $54.79 $22,858 - $29,038	-530 Reduced 3.59%	14,216 $706,000
Q3 2023 Nov 06, 2023	SELL	$50.95 - $55.2 $42,339 - $45,871	-831 Reduced 5.33%	14,746 $790,000
Q2 2023 Aug 14, 2023	SELL	$50.45 - $57.18 $33,952 - $38,482	-673 Reduced 4.14%	15,577 $839,000
Q1 2023 May 15, 2023	BUY	$45.86 - $54.45 $4,540 - $5,390	99 Added 0.61%	16,250 $884,000
Q4 2022 Feb 06, 2023	BUY	$38.86 - $48.55 $627,627 - $784,131	16,151 New	16,151 $782,000
Q1 2019 May 14, 2019	BUY	$40.83 - $45.43 $411,933 - $458,343	10,089 New	10,089 $447,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

Stay updated on Gyl Financial Synergies, LLC with notifications on news.